Schedule 13G ownership disclosure

INFINITY PHARMACEUTICALS, INC.

Security class unavailable · CUSIP: 45665G303

Event date: 2020-09-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001493152-20-018037
Form type
SC 13G
Filer
INFINITY PHARMACEUTICALS, INC.
CIK
CIK 1113148
Filed
Sep 21, 2020
Reporting period
Sep 09, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub